FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293067027> ?p ?o ?g. }

• W4293067027 abstract "Objective: This study aimed to identify specific dysregulated genes with potential diagnostic and predictive values for JAK2V617F + myelofibrosis. Methods: Two gene expression datasets of CD34 + hematopoietic stem and progenitor cells (HSPCs) from patients with JAK2V617F + myeloproliferative neoplasm (MPN) [ n = 66, including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF)] and healthy controls (HC) ( n = 30) were acquired from the GEO (Gene Expression Omnibus) database. The differentially expressed genes (DEGs) were screened between each JAK2V617F + MPN entity and HC. Subsequently, functional enrichment analyses, including Kyoto Encyclopedia of Genes and Genomes (KEGG), Reactome, and Gene Set Enrichment Analysis (GSEA), were conducted to decipher the important biological effects of DEGs. Protein–protein interaction (PPI) networks of the DEGs were constructed to identify hub genes and significant modules. Another two gene expression profiles of patients with JAK2V617F + MPN [ n = 23, including PV, ET, secondary myelofibrosis (SMF), and PMF] and HC ( n = 6) from GEO were used as external validation datasets to prove the reliability of the identified signatures. Results: KEGG analysis revealed the upregulated genes in three JAK2V617F + MPN entities compared with HC were essentially enriched in inflammatory pathways and immune response signaling pathways, and the number of these pathways enriched in PMF was obviously more than that in PV and ET. Following the PPI analysis, 10 genes primarily related to inflammation and immune response were found upregulated in different JAK2V617F + MPN entities. In addition, Reactome enrichment analysis indicated that interferon signaling pathways were enriched specifically in PMF but not in PV or ET. Furthermore, several interferon (IFN)-stimulated genes were identified to be uniquely upregulated in JAK2V617F + PMF. The external datasets validated the upregulation of four interferon-related genes ( OAS1 , IFITM3 , GBP1 , and GBP2 ) in JAK2V617F + myelofibrosis. The receiver operating characteristic (ROC) curves indicate that the four genes have high area under the ROC curve (AUC) values when distinguishing JAK2V617F + myelofibrosis from PV or ET. Conclusion: Four interferon-stimulated genes ( OAS1 , IFITM3 , GBP1 , and GBP2 ) exclusively upregulated in JAK2V617F + myelofibrosis might have the potential to be the auxiliary molecular diagnostic and predictive indicators of myelofibrosis." @default.
• W4293067027 created "2022-08-26" @default.
• W4293067027 creator A5013197185 @default.
• W4293067027 creator A5052304130 @default.
• W4293067027 creator A5054023850 @default.
• W4293067027 creator A5065324321 @default.
• W4293067027 creator A5075141369 @default.
• W4293067027 creator A5087829590 @default.
• W4293067027 date "2022-08-18" @default.
• W4293067027 modified "2023-10-14" @default.
• W4293067027 title "Expression profiles analysis identifies specific interferon-stimulated signatures as potential diagnostic and predictive indicators of JAK2V617F+ myelofibrosis" @default.
• W4293067027 cites W1906297732 @default.
• W4293067027 cites W1980568348 @default.
• W4293067027 cites W1988879621 @default.
• W4293067027 cites W1991035113 @default.
• W4293067027 cites W1993072636 @default.
• W4293067027 cites W2007570437 @default.
• W4293067027 cites W2009954157 @default.
• W4293067027 cites W2010872865 @default.
• W4293067027 cites W2018160762 @default.
• W4293067027 cites W2018622942 @default.
• W4293067027 cites W2028961479 @default.
• W4293067027 cites W2035618305 @default.
• W4293067027 cites W2056278417 @default.
• W4293067027 cites W2057360098 @default.
• W4293067027 cites W2079552505 @default.
• W4293067027 cites W2081331674 @default.
• W4293067027 cites W2095442126 @default.
• W4293067027 cites W2096173332 @default.
• W4293067027 cites W2103912979 @default.
• W4293067027 cites W2115351357 @default.
• W4293067027 cites W2130410032 @default.
• W4293067027 cites W2133402546 @default.
• W4293067027 cites W2136850043 @default.
• W4293067027 cites W2144664431 @default.
• W4293067027 cites W2146512944 @default.
• W4293067027 cites W2153947402 @default.
• W4293067027 cites W2159675211 @default.
• W4293067027 cites W2163043242 @default.
• W4293067027 cites W2172557341 @default.
• W4293067027 cites W2178572105 @default.
• W4293067027 cites W2339658711 @default.
• W4293067027 cites W2405712018 @default.
• W4293067027 cites W2558736960 @default.
• W4293067027 cites W2566942178 @default.
• W4293067027 cites W2567208701 @default.
• W4293067027 cites W2621524439 @default.
• W4293067027 cites W2736512538 @default.
• W4293067027 cites W2774278300 @default.
• W4293067027 cites W2896385413 @default.
• W4293067027 cites W2900692867 @default.
• W4293067027 cites W2911435756 @default.
• W4293067027 cites W2913605210 @default.
• W4293067027 cites W2922693224 @default.
• W4293067027 cites W2944778862 @default.
• W4293067027 cites W2990908755 @default.
• W4293067027 cites W3130936559 @default.
• W4293067027 cites W3132068389 @default.
• W4293067027 cites W3192852744 @default.
• W4293067027 cites W3209270855 @default.
• W4293067027 cites W4206959743 @default.
• W4293067027 cites W4254687493 @default.
• W4293067027 doi "https://doi.org/10.3389/fgene.2022.927018" @default.
• W4293067027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36061178" @default.
• W4293067027 hasPublicationYear "2022" @default.
• W4293067027 type Work @default.
• W4293067027 citedByCount "0" @default.
• W4293067027 crossrefType "journal-article" @default.
• W4293067027 hasAuthorship W4293067027A5013197185 @default.
• W4293067027 hasAuthorship W4293067027A5052304130 @default.
• W4293067027 hasAuthorship W4293067027A5054023850 @default.
• W4293067027 hasAuthorship W4293067027A5065324321 @default.
• W4293067027 hasAuthorship W4293067027A5075141369 @default.
• W4293067027 hasAuthorship W4293067027A5087829590 @default.
• W4293067027 hasBestOaLocation W42930670271 @default.
• W4293067027 hasConcept C104317684 @default.
• W4293067027 hasConcept C109159458 @default.
• W4293067027 hasConcept C127561419 @default.
• W4293067027 hasConcept C150194340 @default.
• W4293067027 hasConcept C152724338 @default.
• W4293067027 hasConcept C162317418 @default.
• W4293067027 hasConcept C18431079 @default.
• W4293067027 hasConcept C203014093 @default.
• W4293067027 hasConcept C2776178377 @default.
• W4293067027 hasConcept C2778837598 @default.
• W4293067027 hasConcept C2780007613 @default.
• W4293067027 hasConcept C2780076729 @default.
• W4293067027 hasConcept C2781057849 @default.
• W4293067027 hasConcept C2781107747 @default.
• W4293067027 hasConcept C28328180 @default.
• W4293067027 hasConcept C502942594 @default.
• W4293067027 hasConcept C54355233 @default.
• W4293067027 hasConcept C70721500 @default.
• W4293067027 hasConcept C86803240 @default.
• W4293067027 hasConceptScore W4293067027C104317684 @default.
• W4293067027 hasConceptScore W4293067027C109159458 @default.
• W4293067027 hasConceptScore W4293067027C127561419 @default.
• W4293067027 hasConceptScore W4293067027C150194340 @default.
• W4293067027 hasConceptScore W4293067027C152724338 @default.
• W4293067027 hasConceptScore W4293067027C162317418 @default.

• next